Fluoxetine
Indication
Depressive illness, Bulimia Nervosa, Obsessive Compulsive Disorder
MHRA Drug Safety Update - Fluoxetine: possible small risk of congenital cardiac defects
Green
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
Recommendation
LSCMMG Recommendation:
Green
Reason for decision:
Suitable for initiation in primary care
Supporting documents: